Skip to main content

Table 1 Incidence and prevalence of isolated candida species among different patient categories using VITEK2 YST® platform

From: The emergence of non-albicans candidemia and evaluation of HiChrome Candida differential agar and VITEK2 YST® platform for differentiation of Candida bloodstream isolates in teaching hospital Kandy, Sri Lanka

Category of patients Candida isolates in blood culture from VITEK2 YST® platform Number of cases Period prevalence (%) Incidence/100,000-person years Comments and p value
Overall C. albicans 34 1.7 X 10 −4% 0.113 0.03 non- albicans period prevalence and incidence was significantly higher than candidemia following albicans
Non- albicans 76 4.1 X 10 −4% 0.23
C. parapsilosis 22 1.1 X 10 −4% 0.07
C. tropicalis 18 1.0 X 10 −4% 0.06
C. krusei 12 8 X 10 −5% 0.04
C. glabrata 12 8 X 10 − 5% 0.04
C. haemulonii 6 4 X 10 −5% 0.02
Other 6 4 X 10 −5% 0.02
Neonates in intensive care units C. albicans 2 2 X 10 −3% 0.133 0.02 non- albicans period prevalence and incidence was significantly higher than candidemia following albicans
Non- albicans 8 9 X 10−3% 0.6
C. parapsilosis 1 2 X 10 −3% 0.133
C. tropicalis 3 3 X 10 −3% 0.2
C. krusei 1 2 X 10 −3% 0.133
C. glabrata 2 2 X 10 −3% 0.133-
C. haemulonii 0   
Infants in intensive care units C. albicans 6 3 X 10–3% 0.2 0.04 non- albicans period prevalence and incidence was significantly higher than candidemia following albicans
Non- albicans 7 6 X 10–3% 0.4
C. parapsilosis 1 2 X 10–3% 0.133
C. tropicalis 3 1.5 X 10–3% 0.1
C. glabrata 2 1.5 X 10–3% 0.066
C. krusei 1 1 X 10–3% 0.066
C. haemulonii 0   
Adults in intensive care units C. albicans 22 1.8 X 10–4% 0.12 0.02 non- albicans period prevalence and incidence was significantly higher than candidemia following albicans
Non- albicans 56 3.8 X 10–4% 0.25
C. parapsilosis 20 1.4 X 10–4% 0.09
C. tropicalis 12 9 X 10–5% 0.06
C. glabrata 9 6 X 10–5% 0.04
C. krusei 9 6 X 10–5% 0.04
C. haemulonii 6 3 X 10–5% 0.02
Immunocompromised patients (having neutropeniaa) C. albicans 22 1.1 X 10–3% 1.13 0.03 non- albicans period prevalence and incidence was significantly higher than candidemia following albicans
Non- albicans 51 3.4 X 10–3% 1.68
C. tropicalis 16 8 X 10–4% 0.53
C. parapsilosis 10 5 X 10–4% 0.33
C. glabrata 10 5 X 10–4% 0.33
C. krusei 10 5 X 10–4% 0.33
C. haemulonii 5 1.1 X 10–5% 0.16
  1. aNeutropenia – neutrophil count < 500 / mm3; p < 0.05 taken as significant
Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us